{"nct_id":"NCT06194448","title":"To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2024-04-21","start_date_type":"ACTUAL","primary_completion_date":"2026-07-07","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-07","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}